Paul Chariou is an Associate Principal Scientist and R&D cancer immunologist, holding a Ph.D. in biomedical engineering. With 13 years of experience, they have made significant contributions to cell biology, cancer drug delivery and immunotherapy, nanoparticle engineering, and agropesticide delivery. Their research includes the development of innovative cancer vaccines and targeted drug delivery systems, and they have authored 17 peer-reviewed publications in esteemed journals. Previously, Paul has worked at institutions such as the National Cancer Institute and AstraZeneca, where they served as Bioscience Lead in immuno-oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices